Skip to main content

RAYMOND JAMES FINANCIAL INC

Position in OGN — Organon & Co.

CIK 720005 ST. PETERSBURG, FL

Position in OGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,902,176
+$937,847 QoQ
Shares Held
214,341
-34.6% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#100
of 626 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in OGN Over Time

Shares Held

Position Value (USD)

Derivatives in OGN

reported options exposure · as of Dec 31, 2025
CallValue
$253,818
CallShares
35,400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

RAYMOND JAMES FINANCIAL INC holds $10,536,270,733 across 17 Drug Manufacturers - General names. OGN ranks #15 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in OGN

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,902,176 214,341
2026-03-31 $1,964,329 327,935
2025-12-31 $253,818 35,400
2025-12-31 $1,850,088 258,032
2025-09-30 $3,423,376 320,541
2025-06-30 $4,033,558 416,690
2025-03-31 $4,736,923 318,128
2024-12-31 $4,194,161 281,110